Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis

20232 citationsJournal Articlegold Open Access

Authors

Amy D. Shapiro · Indiana Hemophilia and Thrombosis Center

Hérvè Chambost · Aix-Marseille Université

Margareth C. Ozelo · Universidade Estadual de Campinas (UNICAMP)

Aletta Falk · Swedish Orphan Biovitrum (Sweden)

Helena Ahlin · Swedish Orphan Biovitrum (Sweden)

Sandra Casiano · Sanofi (United States)

Elena Santagostino

Abstract

The aggregate analysis and representative cases of major surgeries demonstrate that rFIXFc can achieve FIX levels for effective hemostasis during invasive high-risk procedures.

Topics & Keywords

Hemophilia Treatment and Research Platelet Disorders and Treatments

Publication Details

Published in: Research and Practice in Thrombosis and Haemostasis

Volume 7, Issue 6, pp. 102169-102169

DOI: 10.1016/j.rpth.2023.102169

Field-Weighted Citation Impact: 0.59

Command Palette

Recombinant factor IX Fc for major surgery in hemophilia B: factor IX plasma activity levels and effective hemostasis

Authors

Abstract

Topics & Keywords

Publication Details